Selective Enhancement of Macropinocytosis for the Treatment of Non-Small Cell Lung Cancer
Over the past few years, researchers have focused their attention on the development of targeted cancer therapies to minimize the side effects associated with non-targeted treatments such as chemotherapy. Specifically, these approaches have focused on blocking growth factor receptors (GFR) that are...
Main Author: | Iglesias, Raul |
---|---|
Format: | Others |
Published: |
Scholar Commons
2016
|
Subjects: | |
Online Access: | http://scholarcommons.usf.edu/etd/6098 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=7294&context=etd |
Similar Items
-
Development of elastin-like polypeptide for targeted specific gene delivery in vivo
by: Aena Yi, et al.
Published: (2020-01-01) -
The Arabidopsis ELP3/ELO3 and ELP4/ELO1 genes enhance disease resistance in Fragaria vesca L.
by: Katchen Julliany P. Silva, et al.
Published: (2017-12-01) -
Enhanced Flexible Materials for Valve Prosthesis Applications
by: Lordeus, Makensley
Published: (2015) -
Implementation of European Language Portfolio in Lithuania: Problems and Implications
by: Zita Mažuolienė
Published: (2011-02-01) -
A Multifaceted Analysis of Early Stage Non-Small Cell Lung Cancer Data
by: Behera, Madhusmita
Published: (2012)